vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and OXFORD INDUSTRIES INC (OXM). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $307.3M, roughly 1.6× OXFORD INDUSTRIES INC). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -20.7%, a 10.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -0.2%). OXFORD INDUSTRIES INC produced more free cash flow last quarter ($-47.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -3.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.

CLOV vs OXM — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.6× larger
CLOV
$487.7M
$307.3M
OXM
Growing faster (revenue YoY)
CLOV
CLOV
+45.0% gap
CLOV
44.7%
-0.2%
OXM
Higher net margin
CLOV
CLOV
10.6% more per $
CLOV
-10.1%
-20.7%
OXM
More free cash flow
OXM
OXM
$21.1M more FCF
OXM
$-47.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-3.0%
OXM

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
OXM
OXM
Revenue
$487.7M
$307.3M
Net Profit
$-49.3M
$-63.7M
Gross Margin
60.3%
Operating Margin
-10.1%
-27.7%
Net Margin
-10.1%
-20.7%
Revenue YoY
44.7%
-0.2%
Net Profit YoY
-123.2%
-1517.6%
EPS (diluted)
$-4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
OXM
OXM
Q4 25
$487.7M
$307.3M
Q3 25
$496.6M
$403.1M
Q2 25
$477.6M
$392.9M
Q1 25
$462.3M
Q4 24
$337.0M
$308.0M
Q3 24
$331.0M
$419.9M
Q2 24
$356.3M
$398.2M
Q1 24
$346.9M
$404.4M
Net Profit
CLOV
CLOV
OXM
OXM
Q4 25
$-49.3M
$-63.7M
Q3 25
$-24.4M
$16.7M
Q2 25
$-10.6M
$26.2M
Q1 25
$-1.3M
Q4 24
$-22.1M
$-3.9M
Q3 24
$-9.2M
$40.6M
Q2 24
$7.4M
$38.4M
Q1 24
$-19.2M
$-60.1M
Gross Margin
CLOV
CLOV
OXM
OXM
Q4 25
60.3%
Q3 25
61.4%
Q2 25
64.2%
Q1 25
Q4 24
63.1%
Q3 24
24.5%
63.1%
Q2 24
30.3%
64.9%
Q1 24
23.6%
60.9%
Operating Margin
CLOV
CLOV
OXM
OXM
Q4 25
-10.1%
-27.7%
Q3 25
-4.9%
6.3%
Q2 25
-2.2%
9.2%
Q1 25
-0.3%
Q4 24
-6.4%
-2.0%
Q3 24
-2.7%
12.5%
Q2 24
2.0%
13.2%
Q1 24
-6.5%
-20.1%
Net Margin
CLOV
CLOV
OXM
OXM
Q4 25
-10.1%
-20.7%
Q3 25
-4.9%
4.1%
Q2 25
-2.2%
6.7%
Q1 25
-0.3%
Q4 24
-6.6%
-1.3%
Q3 24
-2.8%
9.7%
Q2 24
2.1%
9.6%
Q1 24
-5.5%
-14.9%
EPS (diluted)
CLOV
CLOV
OXM
OXM
Q4 25
$-4.28
Q3 25
$1.12
Q2 25
$1.70
Q1 25
Q4 24
$-0.25
Q3 24
$2.57
Q2 24
$2.42
Q1 24
$-3.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
OXM
OXM
Cash + ST InvestmentsLiquidity on hand
$78.3M
$8.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$528.0M
Total Assets
$541.0M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
OXM
OXM
Q4 25
$78.3M
$8.0M
Q3 25
$6.9M
Q2 25
$8.2M
Q1 25
Q4 24
$194.5M
$7.0M
Q3 24
$288.0M
$18.4M
Q2 24
$254.8M
$7.7M
Q1 24
$208.3M
$7.6M
Total Debt
CLOV
CLOV
OXM
OXM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$29.0M
Stockholders' Equity
CLOV
CLOV
OXM
OXM
Q4 25
$308.7M
$528.0M
Q3 25
$340.9M
$597.1M
Q2 25
$344.2M
$592.4M
Q1 25
$336.1M
Q4 24
$341.1M
$612.2M
Q3 24
$342.2M
$621.6M
Q2 24
$324.9M
$592.9M
Q1 24
$292.5M
$560.9M
Total Assets
CLOV
CLOV
OXM
OXM
Q4 25
$541.0M
$1.3B
Q3 25
$559.7M
$1.3B
Q2 25
$575.0M
$1.3B
Q1 25
$583.7M
Q4 24
$580.7M
$1.2B
Q3 24
$653.0M
$1.2B
Q2 24
$674.2M
$1.2B
Q1 24
$671.8M
$1.1B
Debt / Equity
CLOV
CLOV
OXM
OXM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
OXM
OXM
Operating Cash FlowLast quarter
$-66.9M
$-9.1M
Free Cash FlowOCF − Capex
$-69.0M
$-47.9M
FCF MarginFCF / Revenue
-14.1%
-15.6%
Capex IntensityCapex / Revenue
0.4%
12.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$-79.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
OXM
OXM
Q4 25
$-66.9M
$-9.1M
Q3 25
$12.1M
$83.5M
Q2 25
$5.4M
$-3.9M
Q1 25
$-16.3M
Q4 24
$34.8M
$-18.2M
Q3 24
$50.0M
$88.8M
Q2 24
$44.8M
$32.9M
Q1 24
$25.9M
$74.9M
Free Cash Flow
CLOV
CLOV
OXM
OXM
Q4 25
$-69.0M
$-47.9M
Q3 25
$11.4M
$52.3M
Q2 25
$4.8M
$-27.4M
Q1 25
$-16.5M
Q4 24
$33.3M
$-56.9M
Q3 24
$49.6M
$47.2M
Q2 24
$44.4M
$21.0M
Q1 24
$25.5M
$55.3M
FCF Margin
CLOV
CLOV
OXM
OXM
Q4 25
-14.1%
-15.6%
Q3 25
2.3%
13.0%
Q2 25
1.0%
-7.0%
Q1 25
-3.6%
Q4 24
9.9%
-18.5%
Q3 24
15.0%
11.2%
Q2 24
12.5%
5.3%
Q1 24
7.3%
13.7%
Capex Intensity
CLOV
CLOV
OXM
OXM
Q4 25
0.4%
12.6%
Q3 25
0.1%
7.7%
Q2 25
0.1%
6.0%
Q1 25
0.0%
Q4 24
0.5%
12.6%
Q3 24
0.1%
9.9%
Q2 24
0.1%
3.0%
Q1 24
0.1%
4.8%
Cash Conversion
CLOV
CLOV
OXM
OXM
Q4 25
Q3 25
5.00×
Q2 25
-0.15×
Q1 25
Q4 24
Q3 24
2.19×
Q2 24
6.04×
0.86×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

OXM
OXM

Sales Channel Retail$162.9M53%
Sales Channel Wholesale$61.3M20%
Johnny Was$45.4M15%
Sales Channel Food And Beverage$29.3M10%
Other Foreign Countries$9.0M3%

Related Comparisons